WELL Health Technologies Corp. (TSE:WELL) Given Average Recommendation of “Buy” by Brokerages

Shares of WELL Health Technologies Corp. (TSE:WELL) have been given an average recommendation of “Buy” by the six research firms that are presently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is C$7.35.

A number of equities research analysts have recently issued reports on the company. Canadian Imperial Bank of Commerce upgraded WELL Health Technologies from a “neutral” rating to an “outperform” rating in a report on Wednesday, December 3rd. Scotiabank dropped their price target on WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating for the company in a report on Wednesday, February 4th.

WELL Health Technologies Stock Performance

TSE WELL opened at C$4.06 on Wednesday. The stock has a market cap of C$1.03 billion, a PE ratio of -45.11, a P/E/G ratio of -1.93 and a beta of 0.49. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14. The firm has a 50-day moving average of C$4.04 and a 200-day moving average of C$4.50. WELL Health Technologies has a 52-week low of C$3.58 and a 52-week high of C$6.35.

WELL Health Technologies (TSE:WELL) last announced its quarterly earnings results on Thursday, November 6th. The company reported C$0.16 EPS for the quarter. The business had revenue of C$364.60 million for the quarter. WELL Health Technologies had a net margin of 7.67% and a return on equity of 8.74%. On average, sell-side analysts anticipate that WELL Health Technologies will post 0.3000698 EPS for the current year.

About WELL Health Technologies

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.